AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
Rheinmetall cuts 2026 sales forecast again as Boxer order slips
Most Americans are “thrilled” or “happy” about the results of this year’s election. Some are especially so.
Qualcomm faces the loss of Apple’s business and the negative impact of high memory costs on overall smartphone demand.
After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
Arm’s third-quarter revenue forecast above estimates but investors unimpressed
Figma’s investments in AI models and agents are driving usage, but the cost of delivering these features is proving to be expensive
Why is Arm stock sliding today?
Coty forecasts soft second-quarter profit as higher costs clouds turnaround efforts
Why is Coherent stock surging today?
Goldman, Apollo seek buyers for $40 billion SpaceX AI chip deal, Bloomberg News reports
Why is Dutch Bros stock tumbling today?
Mexico stocks higher at close of trade; S&P/BMV IPC up 0.87%
Stocks surged, oil prices plunged and bond yields fell Wednesday on optimism around a quicker end to the Iran war now that Democrats have clinched control of Congress.
Investors are flocking to Apple as a safe haven as AI infrastructure names come under pressure from midterm election results
Silicon Valley spent big to kill California’s wealth tax — but incoming Democrats are eyeing a national fight.
Qualcomm falls 3% as handset revenue misses estimates, costs rise
Qualcomm forecasts upbeat sales on strength in non-smartphone segments
Two dead after incident at Citigroup’s complex in Florida
Why is UroGen Pharma stock sliding today?
News text belongs to its source; only the headline and a short summary appear here.